| 1 |
El-Serag HB, Sweet S, Winchester CC, et al.Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
|
| 2 |
屈坤鹏，成晓舟．我国部分地区胃食管反流病患病率的meta分析[J/CD]．中华胃食管反流病电子杂志，2015，2(1)：34-44.
|
| 3 |
赵艳芳，王睿，阎小妍．胃食管反流病对上海市居民生存质量的影响[J]．中国卫生统计，2009，26(4)：363-366.
|
| 4 |
Liu K, Yang K, Zhang W, et al.Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-Institution, High-Volume Experience in China[J]. Ann Surg, 2016, 263(1): 88-95.
|
| 5 |
Cicala M, Emerenziani S, Guarino MP, et al.Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease[J]. World J Gastroenterol, 2013, 19(39): 6529-6535.
|
| 6 |
Boeckxstaens G, El-Serag HB, Smout AJ, et al.Symptomatic reflux disease: the present, the past and the future[J]. Gut, 2014, 63(7): 1185-1193.
|
| 7 |
Herregods TV, Bredenoord AJ, Smout AJ.Pathophysiology of gastroesophageal reflux disease: new understanding in a new era[J]. Neurogastroenterol Motil, 2015, 27(9): 1202-1213.
|
| 8 |
Woodland P, Sifrim D. The refluxate: The impact of its magnitude, composition and distribution[J]. Best Pract Res Clin Gastroenterol, 2010, 24(6): 861-871.
|
| 9 |
Weijenborg PW, Smout AJ, Verseijden C, et al.Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis[J]. Am J Physiol Gastrointest Liver Physiol, 2014, 307(3): G323-329.
|
| 10 |
Emerenziani S, Ribolsi M, Guarino MP, et al.Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients[J]. Neurogastroenterol Motil, 2014, 26(1): 108-114.
|
| 11 |
Zerbib F, Duriez A, Roman S, et al.Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors[J]. Gut, 2008, 57(2): 156-160.
|
| 12 |
Woodland P, Aktar R, Mthunzi E, et al.Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 308(6): G525-531.
|
| 13 |
Kahrilas PJ, Keefer L, Pandolfino JE.Patients with refractory reflux symptoms: What do they have and how should they be managed? [J]. Neurogastroenterol Motil, 2015, 27(9): 1195-1201.
|
| 14 |
Mullin JM, Gabello M, Murray LJ, et al.Proton pump inhibitors: actions and reactions[J]. Drug Discov Today, 2009, 14(13/14): 647-660.
|
| 15 |
仇明，张伟．胃排空障碍与胃食管反流病[J/CD]．中华胃食管反流病电子杂志，2015，2(1)：1-3.
|
| 16 |
Yurtsever AS, Pektas M, Ozkur M, et al.Proton pump inhibitors omeprazole, lansoprazole and pantoprazole induce relaxation in the rat lower oesophageal sphincter[J]. J Pharm Pharmacol, 2011, 63(10): 1295-1300.
|
| 17 |
Mullin JM, Valenzano MC, Whitby M, et al.Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase[J]. Aliment Pharmacol Ther, 2008, 28(11/12): 1317-1325.
|
| 18 |
Ichikawa H, Sugimoto M, Sugimoto K, et al.Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis[J]. J Gastroenterol Hepatol, 2015, Nov 18.
|
| 19 |
Zerbib F, Bruley des Varannes S, Simon M, et al.Functional heartburn: definition and management strategies[J]. Curr Gastroenterol Rep, 2012, 14(3): 181-188.
|
| 20 |
Kahrilas PJ, Boeckxstaens G, Smout AJ.Management of the patient with incomplete response to PPI therapy[J]. Best Pract Res Clin Gastroenterol, 2013, 27(3): 401-414.
|
| 21 |
Frazzoni M, Piccoli M, Conigliaro R, et al.Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication[J]. Surg Endosc, 2013, 27(8): 2940-2946.
|